New paper out in www-sciencedirect-com.ezproxy.u-paris.fr/science/arti... An 8-gene signature (FFPE-compatible)+ mucinous component identifies dMMR/MSI-H mCRC patients who benefit most from anti-PD-1 + anti-CTLA-4 combo: → 24-mo PFS 72% vs 14% (HR 0.10, p<0.001) @crcordeliers.bsky.social
Université Paris Cité - Service d'authentification - Stale Request
www-sciencedirect-com.ezproxy.u-paris.fr